Get the Stockscreener App
404.58
1.89%
-7.80
Overview
News
Price History
Option Chain
Financials
Why ELV Down?
Discussions
Forecast
Stock Split
Dividend History
Elevance Health Inc stock is traded at $404.58, with a volume of 948.11K.
It is down -1.89% in the last 24 hours and down -7.14% over the past month.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of December 2024. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
See More
Previous Close:
$412.38
Open:
$412.62
24h Volume:
948.11K
Relative Volume:
0.61
Market Cap:
$92.63B
Revenue:
$183.12B
Net Income/Loss:
$5.92B
P/E Ratio:
15.79
EPS:
25.63
Net Cash Flow:
$3.67B
1W Performance:
-1.32%
1M Performance:
-7.14%
6M Performance:
-4.27%
1Y Performance:
-24.88%
1-Day Range:
$402.11
$413.67
1-Week Range:
$402.11
$419.99
52-Week Range:
$362.21
$567.26
Elevance Health Inc Stock (ELV) Company Profile
Name
Elevance Health Inc
Sector
Industry
Phone
(800) 331-1476
Address
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
404.58 | 92.63B | 183.12B | 5.92B | 3.67B | 25.63 |
|
UNH
Unitedhealth Group Inc
|
380.64 | 364.02B | 410.06B | 22.11B | 24.86B | 23.88 |
|
CI
Cigna Group
|
333.46 | 89.43B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
66.97 | 85.34B | 378.96B | 5.28B | 5.94B | 4.19 |
|
HUM
Humana Inc
|
249.53 | 31.20B | 117.76B | 1.21B | 2.39B | 9.95 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-17-25 | Upgrade | Argus | Hold → Buy |
| Jan-22-25 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-18-24 | Downgrade | Argus | Buy → Hold |
| Jul-18-24 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-24-24 | Initiated | Morgan Stanley | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Apr-27-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-28-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Sep-09-22 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-22-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
View All
Elevance Health Inc Stock (ELV) Latest News
These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Reasonably Well - Yahoo Finance
Elevance Health, Inc. (ELV): Among the Cheap ESG Stocks to Buy According to Hedge Funds - Insider Monkey
The DOJ files a lawsuit against Elevance Health, Humana and Aetna. - Benzinga
Investors Met With Slowing Returns on Capital At Elevance Health (NYSE:ELV) - Yahoo Finance
US accuses health insurers, brokers of Medicare Advantage kickback scheme - Reuters
Here's How Much $1000 Invested In Elevance Health 20 Years Ago Would Be Worth Today - Benzinga
US Claims Medicare Insurers, Brokers Used Illegal Kickbacks - Yahoo Finance
DOJ accuses health insurance giants of role in Medicare kickback scheme - Cleveland.com
Justice Department hits Aetna, Humana, Elevance Health with Medicare Advantage kickback complaint - Fierce Healthcare
Elevance Health Insiders Sell US$6.9m Of Stock, Possibly Signalling Caution - Yahoo Finance
Inova and Anthem Announce New Contract for Virginians - Business Wire
Elevance Health, Inc. (ELV): Among the Best Stocks to Buy According to D1 Capital’s Daniel Sundheim - Insider Monkey
Elevance Curbs Online Medicare Sign-Ups as Expenses Rise (ELV) - Bloomberg
Mental health network misled policyholders about provider options, lawsuit claims - Reuters
Elevance Nurses Say Their Right To OT Is Beyond Dispute - Law360
Let’s talk tariffs, and no Amazon Prime subscription with your MA plan - statnews.com
Elevance Health to slash Medicare Advantage marketing - Modern Healthcare
Is Elevance (ELV) an Attractively Valued Stock? - MSN
Elevance Health’s MLR Beat Encourages Worried Wall Street - AIS Health
Argus Adjusts Price Target on Elevance Health to $465 From $450 - marketscreener.com
‘Medicaid to the Rescue,’ Says Wall St. Analyst About Elevance Health (ELV) Stock - markets.businessinsider.com
Elevance Health (ELV) Gets a Buy from Barclays - The Globe and Mail
Elevance Health: Carelon Growth, Not Fully Appreciated (NYSE:ELV) - Seeking Alpha
Elevance health projects $34.15-$34.85 EPS for 2025 with focus on Carelon expansion - MSN
Deutsche Bank Cuts Elevance Health Price Target to $463 From $465, Maintains Buy Rating - marketscreener.com
Jefferies Adjusts Price Target on Elevance Health to $488 From $461, Maintains Buy Rating - marketscreener.com
Cantor maintains Elevance stock with $485 target, Overweight rating - Investing.com
Why Elevance Health, Inc. (ELV) is Among the Best Stocks That Will Always Grow - Yahoo Finance
Elevance Health (ELV) Maintains Dividend, Affirms 2025 Outlook - GuruFocus
Elevance Health Inc. (NYSE:ELV) Q1 2025 Earnings Call Transcript - Insider Monkey
Barclays Increases Price Target for Elevance Health (ELV) to $52 - GuruFocus
Elevance Health Inc (ELV) Q1 2025 Earnings Call Highlights: Strong EPS Growth and Strategic ... - Yahoo Finance
Elevance Health Inc (ELV) Q1 2025 Earnings Call Highlights: Strong EPS Growth and Strategic ... By GuruFocus - Investing.com Canada
Elevance Health Inc (ELV) Q1 2025 Earnings Call Highlights: Strong EPS Growth and Strategic Expansions - GuruFocus
Elevance Health: Q1 Earnings Snapshot - CT Insider
Elevance Health Reports Strong Q1 2025 Results - TipRanks
Elevance dodges high MA medical costs that sunk United - Healthcare Brew
Elevance Health Q1 2025 Earnings Call Highlights - TipRanks
Despite Medicaid pressures, Elevance reports strong Q1 earnings - InsuranceNewsNet
Elevance Health's Q1 Earnings Beat Estimates on Rising Premiums - Yahoo Finance
Elevance Health, Inc. SEC 10-Q Report - TradingView
Elevance Health execs seek to ease Wall Street's concerns about elevated MA costs - Fierce Healthcare
Elevance Health (ELV) Q1 2025 Earnings Report Highlights Growth - GuruFocus
Elevance Health Inc (ELV) Shares Down 4.72% on Apr 21 - GuruFocus
Barclays Adjusts Elevance Health Price Target to $522 From $512, Keeps Overweight Rating - marketscreener.com
Elevance says healthcare demand tracks expectations after UnitedHealth's forecast cut - marketscreener.com
Despite Medicaid Pressure, Elevance Health Delivers Strong Q1 Performance, Reiterates Profit Outlook - Yahoo Finance
Elevance Health beats Q1 expectations, reaffirms 2025 outlook - Investing.com
Elevance reports lower-than-expected medical costs, confirms profit beat - Reuters
Earnings call transcript: Elevance Health Q1 2025 beats EPS forecast - Investing.com
Is Elevance Health (ELV) The Top Falling Stock with Unusual Volume? - MSN
Elevance Health Inc Stock (ELV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
1.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):